Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease

Journal of Hepatology

Volumn 39, Issue 2, 2003, Pages 239-244

  Colloredo, Guido ^a   Guido, Maria ^b,e,f   Sonzogni, Aurelio ^c   Leandro, Gioacchino ^d  

^a Seriate Hospital   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d Ist Gastroenterologico 'S De B'   (Italy)

^e Istituto di Anatomia Patologica   (Italy)

^f Medical Division   (Italy)

Author keywords

Chronic hepatitis; Grading; Liver biopsy; Sample size; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; VIRUS HEPATITIS;

EID: 0042671303     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00191-0     Document Type: Article

References (22)

1. Dienstang JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002;36:S152-60.
2. Lok AS. Hepatitis B infection: pathogenesis and management. J Hepatol 2000;32(Suppl 1):89-97.
3. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 2001;33:196-200.
4. Booth JC, O'Grady J, Neuberger J. Clinical guidelines of the management of hepatitis C. Gut 2001;49(S1):1-21.
5. Leung N. Treatment of chronic hepatitis B: case selection and duration of therapy. J Gastroenterol Hepatol 2002;17:409-14.
6. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
7. The French METAVIR cooperative study group, Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
8. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
9. Goldin RD, Goldin GJ, Burt AD, Dhillon AD, Hubscher S, Wyatt J, et al. Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis. J Hepatol 1996;25:649-54.
10. Westin J, Lagging LM, Weistal R, Norkrans G, Dhillon AP. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999;19:183-7.
11. Abdi W, Milln JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139:667-9.
12. Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 1980;15:329-35.
13. Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 1983;18:27-32.
14. Maharaj B, Maharaj MG, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-5.
15. Sherlock S. Needle biopsy of the liver. Diseases of the liver and biliary system. Sherlock S, Dooley J (Eds.). Oxford/London/Edinburgh/Boston/Melbourne: Blackwell scientific publication; 2001. p. 43.
16. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
17. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta-blockade during and after myocardial infarction: an overview of randomised trials. Prog Cardiovasc Dis 1985;27:335-71.
18. Altman DG. Inter-rater agreement, 1st ed. Chapmann and Hall (Eds.). Practical statistics for medical research, London: Chapman and Hall; 1991. p. 403-9.
19. Svensson E, Starmar KJE, Ekholm S, von Essen C, Johansson A. Analysis of interobserver disagreement in the assessment of subarachnoid blood and acute hydrocephalus on CT scan. Neurol Res 1996;18:487-94.
20. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-40.
21. for the METAVIR, CLINIVIR, and DOSVIRC groups, Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-32.
22. Rozario R, Ramakrishna B. Histopathological study of chronic hepatitis B and C: a comparison of two scoring systems. J Hepatol 2003;38:223-9.